{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T20:00:45Z","timestamp":1769112045127,"version":"3.49.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2022,8,24]],"date-time":"2022-08-24T00:00:00Z","timestamp":1661299200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,8,24]],"date-time":"2022-08-24T00:00:00Z","timestamp":1661299200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1007\/s00415-022-11323-4","type":"journal-article","created":{"date-parts":[[2022,8,24]],"date-time":"2022-08-24T17:03:13Z","timestamp":1661360593000},"page":"6605-6612","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Microembolic signals and antiplatelet therapy in Moyamoya angiopathy"],"prefix":"10.1007","volume":"269","author":[{"given":"Mosche","family":"Pompsch","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roland","family":"Veltkamp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rolf R.","family":"Diehl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5667-3621","authenticated-orcid":false,"given":"Markus","family":"Kraemer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,8,24]]},"reference":[{"issue":"12","key":"11323_CR1","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1056\/NEJMra0804622","volume":"360","author":"RM Scott","year":"2009","unstructured":"Scott RM, Smith ER (2009) Moyamoya disease and moyamoya syndrome. N Engl J Med 360(12):1226\u20131237. https:\/\/doi.org\/10.1056\/NEJMra0804622","journal-title":"N Engl J Med"},{"issue":"11","key":"11323_CR2","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1016\/s1474-4422(08)70240-0","volume":"7","author":"S Kuroda","year":"2008","unstructured":"Kuroda S, Houkin K (2008) Moyamoya disease: current concepts and future perspectives. Lancet Neurol 7(11):1056\u20131066. https:\/\/doi.org\/10.1016\/s1474-4422(08)70240-0","journal-title":"Lancet Neurol"},{"issue":"1","key":"11323_CR3","doi-asserted-by":"publisher","first-page":"21","DOI":"10.5853\/jos.2015.01739","volume":"18","author":"T Kim","year":"2016","unstructured":"Kim T, Oh CW, Bang JS, Kim JE, Cho WS (2016) Moyamoya disease: treatment and outcomes. J Stroke 18(1):21\u201330. https:\/\/doi.org\/10.5853\/jos.2015.01739","journal-title":"J Stroke"},{"issue":"3","key":"11323_CR4","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1159\/000083246","volume":"19","author":"P Horn","year":"2005","unstructured":"Horn P, Lanczik O, Vajkoczy P, Daffertshofer M, Bueltmann E, Werner A, Schmiedek P, Hennerici M (2005) Hemodynamic reserve and high-intensity transient signals in moyamoya disease. Cerebrovasc Dis (Basel, Switzerland) 19(3):141\u2013146. https:\/\/doi.org\/10.1159\/000083246","journal-title":"Cerebrovasc Dis (Basel, Switzerland)"},{"issue":"1","key":"11323_CR5","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1161\/strokeaha.116.014529","volume":"48","author":"DY Kim","year":"2017","unstructured":"Kim DY, Son JP, Yeon JY, Kim GM, Kim JS, Hong SC, Bang OY (2017) Infarct pattern and collateral status in adult Moyamoya disease: a multimodal magnetic resonance imaging study. Stroke 48(1):111\u2013116. https:\/\/doi.org\/10.1161\/strokeaha.116.014529","journal-title":"Stroke"},{"issue":"1","key":"11323_CR6","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1136\/jnnp.2009.181487","volume":"82","author":"HJ Cho","year":"2011","unstructured":"Cho HJ, Jung YH, Kim YD, Nam HS, Kim DS, Heo JH (2011) The different infarct patterns between adulthood-onset and childhood-onset moyamoya disease. J Neurol Neurosurg Psychiatry 82(1):38\u201340. https:\/\/doi.org\/10.1136\/jnnp.2009.181487","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1","key":"11323_CR7","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1111\/j.1468-1331.2011.03481.x","volume":"19","author":"M Kraemer","year":"2012","unstructured":"Kraemer M, Berlit P, Diesner F, Khan N (2012) What is the expert\u2019s option on antiplatelet therapy in Moyamoya disease? Results of a worldwide Survey. Eur J Neurol 19(1):163\u2013167. https:\/\/doi.org\/10.1111\/j.1468-1331.2011.03481.x","journal-title":"Eur J Neurol"},{"issue":"12","key":"11323_CR8","doi-asserted-by":"publisher","first-page":"3605","DOI":"10.1016\/j.jstrokecerebrovasdis.2018.08.030","volume":"27","author":"K Oki","year":"2018","unstructured":"Oki K, Katsumata M, Izawa Y, Takahashi S, Suzuki N, Houkin K, Research Committee on Spontaneous Occlusion of Circle of W (2018) Trends of antiplatelet therapy for the management of Moyamoya disease in Japan: results of a nationwide survey. J Stroke Cerebrovasc Dis 27(12):3605\u20133612. https:\/\/doi.org\/10.1016\/j.jstrokecerebrovasdis.2018.08.030","journal-title":"J Stroke Cerebrovasc Dis"},{"issue":"4","key":"11323_CR9","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1177\/23969873211060819","volume":"6","author":"P Sudheer","year":"2021","unstructured":"Sudheer P, Misra S, Nath M, Kumar P, Vibha D, Srivastava MVP, Tripathi M, Bhatia R, Pandit AK, Singh RK (2021) Micro-embolic signal monitoring in stroke subtypes: a systematic review and meta-analysis of 58 studies. Eur Stroke J 6(4):403\u2013411. https:\/\/doi.org\/10.1177\/23969873211060819","journal-title":"Eur Stroke J"},{"issue":"2","key":"11323_CR10","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1161\/01.str.28.2.358","volume":"28","author":"U Sliwka","year":"1997","unstructured":"Sliwka U, Lingnau A, Stohlmann WD, Schmidt P, Mull M, Diehl RR, Noth J (1997) Prevalence and time course of microembolic signals in patients with acute stroke. A prospective study. Stroke 28(2):358\u2013363. https:\/\/doi.org\/10.1161\/01.str.28.2.358","journal-title":"Stroke"},{"issue":"12","key":"11323_CR11","doi-asserted-by":"publisher","first-page":"2832","DOI":"10.1161\/01.STR.0000147035.31297.b6","volume":"35","author":"S Gao","year":"2004","unstructured":"Gao S, Wong KS, Hansberg T, Lam WW, Droste DW, Ringelstein EB (2004) Microembolic signal predicts recurrent cerebral ischemic events in acute stroke patients with middle cerebral artery stenosis. Stroke 35(12):2832\u20132836. https:\/\/doi.org\/10.1161\/01.STR.0000147035.31297.b6","journal-title":"Stroke"},{"issue":"4","key":"11323_CR12","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1159\/000348649","volume":"35","author":"D Jussen","year":"2013","unstructured":"Jussen D, Horn P, Vajkoczy P (2013) Aspirin resistance in patients with hemodynamic cerebral ischemia undergoing extracranial-intracranial bypass surgery. Cerebrovasc Dis (Basel, Switzerland) 35(4):355\u2013362. https:\/\/doi.org\/10.1159\/000348649","journal-title":"Cerebrovasc Dis (Basel, Switzerland)"},{"issue":"5","key":"11323_CR13","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1161\/STROKEAHA.118.022490","volume":"50","author":"C Jeon","year":"2019","unstructured":"Jeon C, Yeon JY, Jo KI, Hong SC, Kim JS (2019) Clinical role of microembolic signals in adult Moyamoya disease with ischemic stroke. Stroke 50(5):1130\u20131135. https:\/\/doi.org\/10.1161\/STROKEAHA.118.022490","journal-title":"Stroke"},{"issue":"5","key":"11323_CR14","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1111\/ene.12392","volume":"21","author":"J Chen","year":"2014","unstructured":"Chen J, Duan L, Xu WH, Han YQ, Cui LY, Gao S (2014) Microembolic signals predict cerebral ischaemic events in patients with moyamoya disease. Eur J Neurol 21(5):785\u2013790. https:\/\/doi.org\/10.1111\/ene.12392","journal-title":"Eur J Neurol"},{"key":"11323_CR15","doi-asserted-by":"publisher","first-page":"425","DOI":"10.3389\/fneur.2017.00425","volume":"8","author":"JG Shulman","year":"2017","unstructured":"Shulman JG, Snider S, Vaitkevicius H, Babikian VL, Patel NJ (2017) Direct visualization of arterial emboli in Moyamoya syndrome. Front Neurol 8:425. https:\/\/doi.org\/10.3389\/fneur.2017.00425","journal-title":"Front Neurol"},{"key":"11323_CR16","doi-asserted-by":"publisher","unstructured":"Guidelines for diagnosis and treatment of moyamoya disease (spontaneous occlusion of the circle of Willis) (2012) Neurologia medico-chirurgica 52 (5):245\u2013266. doi:https:\/\/doi.org\/10.2176\/nmc.52.245","DOI":"10.2176\/nmc.52.245"},{"issue":"1","key":"11323_CR17","doi-asserted-by":"publisher","first-page":"19367","DOI":"10.1038\/s41598-021-99009-1","volume":"11","author":"CH Pang","year":"2021","unstructured":"Pang CH, Cho W-S, Kang H-S, Kim JE (2021) Benefits and risks of antiplatelet medication in hemodynamically stable adult moyamoya disease. Sci Rep 11(1):19367. https:\/\/doi.org\/10.1038\/s41598-021-99009-1","journal-title":"Sci Rep"},{"issue":"5","key":"11323_CR18","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.120.017701","volume":"10","author":"WK Seo","year":"2021","unstructured":"Seo WK, Kim JY, Choi EH, Kim YS, Chung JW, Saver JL, Bang OY, Kim GM (2021) Association of antiplatelet therapy, including cilostazol, with improved survival in patients with Moyamoya disease in a Nationwide Study. J Am Heart Assoc 10(5):e017701. https:\/\/doi.org\/10.1161\/JAHA.120.017701","journal-title":"J Am Heart Assoc"},{"issue":"3","key":"11323_CR19","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2015-009942","volume":"6","author":"D Onozuka","year":"2016","unstructured":"Onozuka D, Hagihara A, Nishimura K, Kada A, Nakagawara J, Ogasawara K, Ono J, Shiokawa Y, Aruga T, Miyachi S, Nagata I, Toyoda K, Matsuda S, Suzuki A, Kataoka H, Nakamura F, Kamitani S, Nishimura A, Kurogi R, Sayama T, Iihara K, Collaborators tJ-AS (2016) Prehospital antiplatelet use and functional status on admission of patients with non-haemorrhagic moyamoya disease: a nationwide retrospective cohort study (J-ASPECT study). BMJ Open 6(3):e009942. https:\/\/doi.org\/10.1136\/bmjopen-2015-009942","journal-title":"BMJ Open"},{"issue":"11","key":"11323_CR20","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1001\/archneur.55.11.1475","volume":"55","author":"LR Caplan","year":"1998","unstructured":"Caplan LR, Hennerici M (1998) Impaired clearance of emboli (washout) is an important link between hypoperfusion, embolism, and ischemic stroke. Arch Neurol 55(11):1475\u20131482. https:\/\/doi.org\/10.1001\/archneur.55.11.1475","journal-title":"Arch Neurol"},{"issue":"3","key":"11323_CR21","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1034\/j.1600-0404.2002.01359.x","volume":"106","author":"RR Diehl","year":"2002","unstructured":"Diehl RR, Samii C, Diehl A (2002) Dynamics and embolic activity of symptomatic intra-cranial cerebral artery stenoses. Acta Neurol Scand 106(3):173\u2013181. https:\/\/doi.org\/10.1034\/j.1600-0404.2002.01359.x","journal-title":"Acta Neurol Scand"},{"issue":"3","key":"11323_CR22","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1111\/jon.12602","volume":"29","author":"O Kargiotis","year":"2019","unstructured":"Kargiotis O, Psychogios K, Safouris A, Magoufis G, Zervas PD, Stamboulis E, Tsivgoulis G (2019) The role of transcranial Doppler monitoring in patients with multi-territory acute embolic strokes: a review. J Neuroimaging 29(3):309\u2013322. https:\/\/doi.org\/10.1111\/jon.12602","journal-title":"J Neuroimaging"},{"issue":"5","key":"11323_CR23","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1007\/s00701-020-04668-0","volume":"163","author":"F Kanamori","year":"2021","unstructured":"Kanamori F, Araki Y, Yokoyama K, Uda K, Mamiya T, Nishihori M, Izumi T, Okamoto S, Natsume A (2021) Effects of aspirin and heparin treatment on perioperative outcomes in patients with Moyamoya disease. Acta Neurochir (Wien) 163(5):1485\u20131491. https:\/\/doi.org\/10.1007\/s00701-020-04668-0","journal-title":"Acta Neurochir (Wien)"},{"key":"11323_CR24","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1016\/j.wneu.2017.06.057","volume":"105","author":"Y Zhao","year":"2017","unstructured":"Zhao Y, Zhang Q, Zhang D, Zhao Y (2017) Effect of aspirin in postoperative management of adult ischemic Moyamoya disease. World Neurosurg 105:728\u2013731. https:\/\/doi.org\/10.1016\/j.wneu.2017.06.057","journal-title":"World Neurosurg"},{"issue":"10","key":"11323_CR25","doi-asserted-by":"publisher","first-page":"2370","DOI":"10.1007\/s00415-018-8997-2","volume":"265","author":"M Kraemer","year":"2018","unstructured":"Kraemer M, Sassen J, Karakaya R, Schwitalla JC, Graf J, Albrecht P, Hartung HP, Diehl RR, Berlit P, Laumer R, Diesner F (2018) Moyamoya angiopathy: early postoperative course within 3 months after STA-MCA-bypass surgery in Europe-a retrospective analysis of 64 procedures. J Neurol 265(10):2370\u20132378. https:\/\/doi.org\/10.1007\/s00415-018-8997-2","journal-title":"J Neurol"},{"issue":"5","key":"11323_CR26","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1007\/s00381-020-04991-y","volume":"37","author":"Y Aihara","year":"2021","unstructured":"Aihara Y, Kashiwase S, Chiba K, Yamaguchi K, Okada Y, Kimura T, Kawamata T (2021) Aspirin use and platelet aggregation in ischemic onset-type pediatric moyamoya patients with intractable headaches (moya-ache). Child\u2019s Nerv Syst 37(5):1649\u20131657. https:\/\/doi.org\/10.1007\/s00381-020-04991-y","journal-title":"Child's Nerv Syst"},{"issue":"12","key":"11323_CR27","doi-asserted-by":"publisher","first-page":"2446","DOI":"10.1111\/ene.14439","volume":"27","author":"P Birkeland","year":"2020","unstructured":"Birkeland P, Tharmabalan V, Lauritsen J, Ganesan V, Bjarkam CR, von Weitzel-Mudersbach P (2020) Moyamoya disease in a European setting: a Danish population-based study. Eur J Neurol 27(12):2446\u20132452. https:\/\/doi.org\/10.1111\/ene.14439","journal-title":"Eur J Neurol"},{"issue":"6","key":"11323_CR28","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1111\/ene.12702","volume":"22","author":"G Acker","year":"2015","unstructured":"Acker G, Goerdes S, Schneider UC, Schmiedek P, Czabanka M, Vajkoczy P (2015) Distinct clinical and radiographic characteristics of moyamoya disease amongst European Caucasians. Eur J Neurol 22(6):1012\u20131017. https:\/\/doi.org\/10.1111\/ene.12702","journal-title":"Eur J Neurol"},{"issue":"2","key":"11323_CR29","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1007\/s00415-021-10684-6","volume":"269","author":"S Pilgram-Pastor","year":"2022","unstructured":"Pilgram-Pastor S, Chapot R, Kraemer M (2022) The angiographic presentation of European Moyamoya angiopathy. J Neurol 269(2):997\u20131006. https:\/\/doi.org\/10.1007\/s00415-021-10684-6","journal-title":"J Neurol"},{"issue":"6","key":"11323_CR30","doi-asserted-by":"publisher","first-page":"765","DOI":"10.3109\/02688697.2015.1096902","volume":"29","author":"P Hever","year":"2015","unstructured":"Hever P, Alamri A, Tolias C (2015) Moyamoya angiopathy\u2014is there a Western phenotype? Br J Neurosurg 29(6):765\u2013771. https:\/\/doi.org\/10.3109\/02688697.2015.1096902","journal-title":"Br J Neurosurg"},{"key":"11323_CR31","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-019-09406-w","author":"M Kraemer","year":"2019","unstructured":"Kraemer M, Keyvani K, Berlit P, Diesner F, Marquardt M (2019) Histopathology of Moyamoya angiopathy in a European patient. J Neurol. https:\/\/doi.org\/10.1007\/s00415-019-09406-w","journal-title":"J Neurol"},{"issue":"6","key":"11323_CR32","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1007\/s00415-019-09277-1","volume":"266","author":"M Kraemer","year":"2019","unstructured":"Kraemer M, Schwitalla JC, Diesner F, Aktas O, Hartung HP, Berlit P (2019) Clinical presentation of Moyamoya angiopathy in Europeans: experiences from Germany with 200 patients. J Neurol 266(6):1421\u20131428. https:\/\/doi.org\/10.1007\/s00415-019-09277-1","journal-title":"J Neurol"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-022-11323-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-022-11323-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-022-11323-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,30]],"date-time":"2022-10-30T12:07:53Z","timestamp":1667131673000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-022-11323-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,24]]},"references-count":32,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["11323"],"URL":"https:\/\/doi.org\/10.1007\/s00415-022-11323-4","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,24]]},"assertion":[{"value":"17 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 August 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 August 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Professor Veltkamp reported receiving grants and personal fees from Bayer, BMS, Boehringer Ingelheim, Bristol Myers Squibb, Daiichi-Sankyo, Janssen and Pfizer. Professor Kraemer received honoraria for teaching activities from Roche Pharma and Chugai Pharma.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"This study was approved by the ethics committee of the Medical Faculty of Heinrich-Heine University Duesseldorf, Germany (2019\u2013694).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from the patients for their anonymized information to be published in this article.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"MK.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Guarantor"}}]}}